NCT02309437 is a Phase 2 clinical trial of Oxycodone in Nutrition Disorders, sponsored by Affiliated Cancer Hospital & Institute of Guangzhou Medical University.

Who is sponsoring NCT02309437?

NCT02309437 is sponsored by Affiliated Cancer Hospital & Institute of Guangzhou Medical University.

What drugs are being tested in NCT02309437?

Interventions in NCT02309437: Oxycodone, Oxycodone.

What condition does NCT02309437 study?

NCT02309437 studies Nutrition Disorders, Quality of Life.

Is NCT02309437 still recruiting?

NCT02309437 is currently completed. Last updated 17 July 2018.

Last reviewed 2018-07-17 · How we verify

NCT02309437

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Use of Opioid in Radiation Mucositis

Completed Phase 2 Last updated 17 July 2018

What this trial tests

Phase 2 trial testing Oxycodone in Nutrition Disorders in 200 participants. Completed in 31 December 2017.

Timeline

1 January 2015

Primary endpoint
31 December 2017

31 December 2017

Quick facts

Lead sponsor	Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	200
Start date	1 January 2015
Primary completion	31 December 2017
Estimated completion	31 December 2017
Sites	4 locations across China

Drugs / interventions tested

Oxycodone (oxycodone) — full drug profile →
Oxycodone (oxycodone) — full drug profile →

Conditions studied

Nutrition Disorders — all drugs for Nutrition Disorders →
Quality of Life — all drugs for Quality of Life →

Sponsor

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Who can join

18 and older, any sex, with Nutrition Disorders or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a superiority research to evaluate the safety and effectiveness of early use of oxycodone control release tablet for radiation mucositis in nasopharyngeal carcinoma patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Radiation-Induced Oral Mucositis.
Maria OM, Eliopoulos N, Muanza T. · · 2017 · cited 253× · PMID 28589080 · DOI 10.3389/fonc.2017.00089

Verify or expand the search:

Other trials of Oxycodone

Trials testing the same drug.

NCT07153003 — Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And · Phase 4 · enrolling by invitation
NCT06757140 — Opioid Drug Interaction Study · Phase 1, PHASE2 · recruiting
NCT05965492 — Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery · Phase 3 · withdrawn
NCT06517069 — Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients · NA · recruiting
NCT06340932 — Impact of Opioid Avoidance Protocol for ACL Reconstruction · completed

Other recruiting trials for Nutrition Disorders

Currently open trials in the same condition.

NCT06642337 — Nutritional Educational Program On Therapy in Iron Deficiency Anemia · NA · active not recruiting
NCT06500234 — Nutrition Impact on Immunotherapy of Cancer · Phase 3 · recruiting
NCT05655936 — Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial · NA · recruiting
NCT04475666 — Replacing Protein Via Enteral Nutrition in Critically Ill Patients · NA · recruiting

Other Affiliated Cancer Hospital & Institute of Guangzhou Medical University trials

Trials by the same sponsor.

NCT07286240 — QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer · Phase 2 · recruiting
NCT07286253 — QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial · Phase 2 · recruiting
NCT06594172 — Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy · Phase 2 · not yet recruiting
NCT06570538 — Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy · EARLY_PHASE1 · not yet recruiting
NCT06327932 — HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02309437 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Last refreshed: 17 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02309437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing